Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Enteric Softgel Capsules Market by Type (Gelatin Type, Vegetable Type), By Application (Antacid and Antiflatulent Preparations, Antibiotic and Antibacterial Drugs, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Enteric Softgel Capsules Market by Type (Gelatin Type, Vegetable Type), By Application (Antacid and Antiflatulent Preparations, Antibiotic and Antibacterial Drugs, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 131870 3300 Pharma & Healthcare 377 249 Pages 4.7 (49)
                                          

Market Overview:


The global enteric softgel capsules market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for softgel capsules as an alternative to hard gelatin capsules and tablets, rising prevalence of lifestyle diseases, and growing demand for nutraceuticals and functional foods. Based on type, the global enteric softgel capsules market can be segmented into gelatin type and vegetable type. The gelatin type segment is expected to account for a larger share of the market in 2018 owing to its superior properties such as high tensile strength, water resistance, and compatibility with a wide range of ingredients.


Global Enteric Softgel Capsules Industry Outlook


Product Definition:


Enteric softgel capsules are designed to protect the ingredients from being broken down by stomach acids. This allows the ingredients to be released in the small intestine, where they can be absorbed into the bloodstream. Enteric softgel capsules are used to deliver medications that would otherwise be destroyed by stomach acids, such as certain types of antibiotics and drugs used to treat heartburn or ulcers.


Gelatin Type:


Gelatin is a protein that occurs in the connective tissues of animals and plants. It has been used as an ingredient in pharmaceutical formulations for over two centuries. Gelatin is extracted from animal sources such as bovine, porcine, poultry, and marine; whereas plant-derived gelatin can be obtained from beef bones or seaweed extracts.


Vegetable Type:


The vegetable type is a group of plants that grow underground and above-ground parts of the same plant are used to produce vegetable type enteric softgel capsules. The most commonly used vegetables for producing these capsules include amaranth, artichoke, asparagus, beets, broccoli rabe (Brassica juncea), cabbage leafy greens like kale and chard among others.


Application Insights:


The others application segment accounted for the largest revenue share in 2017. The antibiotic and antibacterial drugs application segment is expected to grow at a significant rate over the forecast period owing to increasing prevalence of infectious diseases, especially among children. Furthermore, rising incidences of chronic diseases are anticipated to boost demand for enteric softgel capsules as they provide easy digestion and reduce gas formation by acting as antacids.


Antacid and antiflatulent preparations are also expected to witness lucrative growth during the forecast period due largely on account of their high consumption in Asia Pacific region. In addition, growing awareness regarding digestive comfort along with an increase in spending capacity is anticipated fuel demand for antacid drugs particularly among high-income class consumers across North America and Europe regions over the next eight years.


Regional Analysis:


Asia Pacific dominated the global enteric softgel capsules market in 2017. The region is expected to maintain its position during the forecast period owing to increasing product consumption for treatment of acid reflux and ulcers, bacterial infections, and as an antibiotic. In addition, rising geriatric population prone to various diseases is anticipated to fuel demand for anti-diarrheal drugs in this region.


The Asia Pacific market was valued at USD X billion in 2017 and is projected to grow at a significant rate over the forecast period due to high unmet medical needs coupled with rapidly growing healthcare expenditure levels in emerging economies such as China & India. Increasing investments by major pharmaceutical companies are also contributing towards growth of this regional market on account of rising awareness regarding benefits of these products over conventional tablets & capsules (mainly due their ease in administration).


Europe accounted for a significant share followed by North America owing mainlyto higher adoption rates observedin countries like Germany, U.K.


Growth Factors:


  • Increasing demand for convenience foods: The growing trend of busy lifestyles has led to an increase in the demand for convenient food options such as enteric softgel capsules. These capsules offer a quick and easy way to consume essential nutrients without having to chew or swallow large tablets.
  • Rising awareness about the health benefits of softgels: There is a growing awareness among consumers about the health benefits of taking supplements in the form of softgels. This is driving demand for enteric softgel capsules, which are seen as a more efficient and effective way to take supplements than traditional tablets or capsules.
  • Growing popularity of natural ingredients: A growing number of consumers are opting for natural ingredients over synthetic ones, due to concerns about the potential side effects of synthetic ingredients. Enteric softgel capsules made with natural ingredients are therefore seeing increasing demand from consumers looking for safe and healthy dietary supplements.

Scope Of The Report

Report Attributes

Report Details

Report Title

Enteric Softgel Capsules Market Research Report

By Type

Gelatin Type, Vegetable Type

By Application

Antacid and Antiflatulent Preparations, Antibiotic and Antibacterial Drugs, Others

By Companies

Catalent, Sirio Pharma, Aenova, ProCaps, InovoBiologic, Alpha, Dart Neuroscience, BASF, Lonza, NutraNorth

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

249

Number of Tables & Figures

175

Customization Available

Yes, the report can be customized as per your need.


Global Enteric Softgel Capsules Market Report Segments:

The global Enteric Softgel Capsules market is segmented on the basis of:

Types

Gelatin Type, Vegetable Type

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Antacid and Antiflatulent Preparations, Antibiotic and Antibacterial Drugs, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Catalent
  2. Sirio Pharma
  3. Aenova
  4. ProCaps
  5. InovoBiologic
  6. Alpha
  7. Dart Neuroscience
  8. BASF
  9. Lonza
  10. NutraNorth

Global Enteric Softgel Capsules Market Overview


Highlights of The Enteric Softgel Capsules Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Gelatin Type
    2. Vegetable Type
  1. By Application:

    1. Antacid and Antiflatulent Preparations
    2. Antibiotic and Antibacterial Drugs
    3. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Enteric Softgel Capsules Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Enteric Softgel Capsules Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available
                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Enteric Softgel Capsules Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Enteric Softgel Capsules Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Enteric Softgel Capsules Market - Supply Chain
   4.5. Global Enteric Softgel Capsules Market Forecast
      4.5.1. Enteric Softgel Capsules Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Enteric Softgel Capsules Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Enteric Softgel Capsules Market Absolute $ Opportunity

5. Global Enteric Softgel Capsules Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Enteric Softgel Capsules Market Size and Volume Forecast by Type
      5.3.1. Gelatin Type
      5.3.2. Vegetable Type
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Enteric Softgel Capsules Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Enteric Softgel Capsules Market Size and Volume Forecast by Application
      6.3.1. Antacid and Antiflatulent Preparations
      6.3.2. Antibiotic and Antibacterial Drugs
      6.3.3. Others
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Enteric Softgel Capsules Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Enteric Softgel Capsules Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Enteric Softgel Capsules Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Enteric Softgel Capsules Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Enteric Softgel Capsules Demand Share Forecast, 2019-2029

9. North America Enteric Softgel Capsules Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Enteric Softgel Capsules Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Enteric Softgel Capsules Market Size and Volume Forecast by Application
      9.4.1. Antacid and Antiflatulent Preparations
      9.4.2. Antibiotic and Antibacterial Drugs
      9.4.3. Others
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Enteric Softgel Capsules Market Size and Volume Forecast by Type
      9.7.1. Gelatin Type
      9.7.2. Vegetable Type
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Enteric Softgel Capsules Demand Share Forecast, 2019-2029

10. Latin America Enteric Softgel Capsules Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Enteric Softgel Capsules Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Enteric Softgel Capsules Market Size and Volume Forecast by Application
      10.4.1. Antacid and Antiflatulent Preparations
      10.4.2. Antibiotic and Antibacterial Drugs
      10.4.3. Others
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Enteric Softgel Capsules Market Size and Volume Forecast by Type
      10.7.1. Gelatin Type
      10.7.2. Vegetable Type
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Enteric Softgel Capsules Demand Share Forecast, 2019-2029

11. Europe Enteric Softgel Capsules Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Enteric Softgel Capsules Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Enteric Softgel Capsules Market Size and Volume Forecast by Application
      11.4.1. Antacid and Antiflatulent Preparations
      11.4.2. Antibiotic and Antibacterial Drugs
      11.4.3. Others
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Enteric Softgel Capsules Market Size and Volume Forecast by Type
      11.7.1. Gelatin Type
      11.7.2. Vegetable Type
   11.8. Basi Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Enteric Softgel Capsules Demand Share, 2019-2029

12. Asia Pacific Enteric Softgel Capsules Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Enteric Softgel Capsules Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Enteric Softgel Capsules Market Size and Volume Forecast by Application
      12.4.1. Antacid and Antiflatulent Preparations
      12.4.2. Antibiotic and Antibacterial Drugs
      12.4.3. Others
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Enteric Softgel Capsules Market Size and Volume Forecast by Type
      12.7.1. Gelatin Type
      12.7.2. Vegetable Type
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Enteric Softgel Capsules Demand Share, 2019-2029

13. Middle East & Africa Enteric Softgel Capsules Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Enteric Softgel Capsules Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Enteric Softgel Capsules Market Size and Volume Forecast by Application
      13.4.1. Antacid and Antiflatulent Preparations
      13.4.2. Antibiotic and Antibacterial Drugs
      13.4.3. Others
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Enteric Softgel Capsules Market Size and Volume Forecast by Type
      13.7.1. Gelatin Type
      13.7.2. Vegetable Type
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Enteric Softgel Capsules Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Enteric Softgel Capsules Market: Market Share Analysis
   14.2. Enteric Softgel Capsules Distributors and Customers
   14.3. Enteric Softgel Capsules Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Catalent
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Sirio Pharma
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Aenova
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. ProCaps
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. InovoBiologic
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Alpha
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Dart Neuroscience
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. BASF
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Lonza
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. NutraNorth
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. COMPANY 11
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us